Study: Low-intensity warfarin has post-THA benefits

05/17/2013 | Healio

Treating patients with low-intensity warfarin for six weeks before total hip arthroplasty was associated with low incidence of bleeding and symptomatic venous thromboembolism in the next three months, according to a study in the journal Thrombosis Research. "Low-intensity warfarin should be considered in future studies to identify the regimen that optimally balances risk of bleeding and symptomatic venous thromboembolism in a real world setting," the authors concluded.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC